We detected the expression of these genes after treatment with PCB, PCBG, MPG, and the reference compound, QCT, which was reported to exert a preventive effect against hepatic steatosis probably through SIRT1/AMPK and PPARα pathways [49,50]. The gene discussed is PPARA; the disease is fatty liver disease.